Stock screenerAll disclosures →
EDGAR →
TNXP
Conviction 0HealthcareScan · Thu, Sep 24, 2026Tonix Pharmaceuticals Holding Corp. (TNXP) closed at $9.67 (-5.57%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 23, RS Rating 7, -61.0% from its 52-week high, -41.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
TNXP$9.67-5.57%
ResistanceSupportVol 14Insider buyVol MA14 443.57K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price9.67
Change-5.57%
Gap-0.98%
Rel volume0.85×
Avg volume449.75K
Avg $ vol5.41M
SMA 2012.19
SMA 5011.87
SMA 20013.79
Price vs 50-18.52%
Price vs 200-29.90%
MA stackbearish
50/200 cross—
Supertrenddown · 11.92
RSI (14)23
MACD hist-0.33
MACD cross—
Stoch %K / %D0 / 4
ADX (14)27
+DI / −DI12 / 28
RSI divergence—
MACD divergence—
ATR %7.14%
ADR %5.24%
52w high24.76
52w low9.51
From 52w high-60.95%
Above 52w low+1.68%
New 52w highNo
SqueezeOff
Bollinger width42.64%
%B0.01
Donchian pos0.21%
Donchian high14.50
Donchian low9.66
AVWAP (52w high)15.60
vs AVWAP high-38.02%
AVWAP (52w low)12.17
vs AVWAP low-20.53%
OBV trendDown
Chaikin MF (20)-0.38
Today vs 20d0.85×
Avg vol (14d)443.57K
Avg vol (20d)449.75K
Avg $ vol (20d)5.41M
Market cap165.85M
RS Rating7 / 99
RS 3m (vs SPY)-23.77%
RS 6m (vs SPY)-52.35%
RS line new highNo
Trend template0/8
Technical rank9.1
1 week-15.32%
1 month-29.21%
3 months-19.28%
6 months-35.53%
1 year-61.76%
YTD-41.57%
P/E-1.34
P/B0.75
P/S12.65
P/FCF-1.61
EPS-14.57
Div yield—
ROE-55.79%
ROA-48.81%
Debt/Eq0.03
Current6.61
EV/EBITDA0.02
Gross margin—
Net margin-946.22%
Rev growth29.85%
EPS growth4.63%
Price target38.00
Target upside292.97%
Analyst ratingBuy
Institutional58.47%
Ent. value-2.89M
Revenue13.54M
Net income-40.55M
Gross profit—
Free cash flow-103.21M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out15.94M
Employees142
ListedFri, Feb 13, 2009
Free float15.62M
Float %98.0%
Short interest3.1M
Days to cover6.4d
Short volume61.7%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$2.44 vs −$2.71
Last surprise+10.0% beat
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank9.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance14.20
Support11.42
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Tonix Pharmaceuticals Holding Corp.: Material event (8-K)SEC EDGAR · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in TNXP
No recent disclosed trades by Congress in TNXP. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TNXP · open-market 4 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
LEDERMAN SETH Chief Executive Officer · Common Stock, $0.001 par value · 2026-08-27 | Buy | 2K | $28K | 2026-08-27 | 2026-08-31 |
BAGGER RICHARD H Director · Common Stock, par value $0.001 · 2026-08-20 | Buy | 1K | $13K | 2026-08-20 | 2026-08-24 |
SAENGER BRADLEY Chief Financial Officer · Common Stock, $0.001 par value · 2026-06-30 | Acquire | 1.45K | $16K | 2026-06-30 | 2026-07-09 |
LEDERMAN SETH Chief Executive Officer · Common Stock, $0.001 par value · 2026-06-09 | Other | — | — | 2026-06-09 | 2026-06-09 |
LEDERMAN SETH Chief Executive Officer · Common Stock, $0.001 par value · 2026-06-09 | Buy | 5K | $59K | 2026-06-09 | 2026-06-09 |
Stillwell Richard Newcomb Director · Common Stock, $0.001 par value · 2026-06-08 | Buy | 5K | $58K | 2026-06-08 | 2026-06-09 |
Stillwell Richard Newcomb Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
BAGGER RICHARD H Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
Hunter James Randolph Jr Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
Treco James Director · Stock Option · 2026-05-12 | Grant | 22.7K | $0 | 2026-05-12 | 2026-05-14 |
SEC filings
EDGAR filings in TNXP · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.